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SMOOTH QUANTILE RATIO ESTIMATION
Francesca Dominici, Leslie Cope, Daniel Q. Naiman, and Scott L. Zeger
October 28, 2003
Abstract
In a study of health care expenditures attributable to smoking, we seek to compare the
distribution of medical costs for persons with lung cancer or chronic obstructive pulmonary
disease (cases) to those without (controls) using a national survey which includes hundreds
of cases and thousands of controls. The distribution of costs is highly skewed toward larger
values, making estimates of the mean from the smaller sample dependent on a small fraction
of the biggest values. One approach to deal with the smaller sample is to rely on a simple
parametric model such as the log-normal, but this makes the undesirable assumption that
the distribution of the log-expenditures is symmetric.
We propose a novel approach to estimate the mean difference of two highly skewed dis-
tributions (∆), which we call Smooth Quantile Ratio Estimation (SQUARE). SQUARE
is obtained by smoothing, over percentiles, the ratio of the cost quantiles of the cases and
controls. SQUARE defines a large class of estimators of ∆ including: 1) the sample mean dif-
ference, 2) the maximum likelihood estimate under log-normal samples, and 3) L-estimates.
We detail asymptotic properties of SQUARE such as consistency and asymptotic normality,
and also provide a closed form expression for the asymptotic variance.
Through a simulation study, we show that SQUARE has lower mean squared error than sev-
eral competitors including the sample mean difference, and log-normal parametric estimates
in several realistic situations. We apply SQUARE to the 1987 National Medicare Expen-
diture Survey to estimate the difference in medical expenditures between persons suffering
from the smoking attributable diseases, lung cancer and chronic obstructive pulmonary dis-
ease, and persons without these diseases. Software in R (Ihaka and Gentleman, 1996) for
the implementation of SQUARE and of all its special cases, and the cost data used in this
paper are available at http://biostat.jhsph.edu/∼fdominic/square.html.
KEYWORDS: Comparing means, skewed distributions, order statistics, log-normal, regres-
sion splines, Q-Q plots, smoking, health expenditures.
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1 Introduction
This paper is motivated by the question of how to estimate smokers’ medical expenditures
attributable to their having lung cancer, chronic obstructive pulmonary disease (COPD) or
other diseases predominantly caused by smoking. As a component of our analysis, we com-
pare medical expenditures between persons with lung cancer or COPD (cases) and persons
without a major smoking attributable disease (controls) in a given year. That is, we seek to
estimate the difference ∆ = E[Y1]−E[Y2] where Y1 and Y2 are random variables representing
the expenditures for a case and control groups, respectively. We estimate ∆ using the 1987
National Medical Expenditure Survey (National Center For Health Services Research, 1987),
one data set on annual medical expenditures and disease status for a representative sample
of U.S. non-institutionalized adults.
This statistical problem is made interesting by two facts. First, the distribution of the non-
zero medical expenditures is highly skewed to large values. Figure 1 shows histograms of
non-zero medical expenditures in NMES with and without a logarithmic transformation.
Ninety percent of the total expenditures is contributed by only forty percent of the people.
Second, we have a much smaller sample of disease cases than controls. Among persons 40
years and older with non-zero expenditures in NMES, only 118 persons have lung cancer or
COPD, while 2262 persons are without a major smoking attributable disease. The problem
addressed in this paper is how to reliably estimate the difference in means from two right-
skewed distributions given two independent samples, one being substantially smaller than
the other.
The problem introduced above is one of a set of problems that arises in studying expenditure
data. These include a significant fraction of zero expenditures, right censoring, and lack of
independence among observations within clusters (Lipscomb et al., 1999). The general prob-
lem of comparing costs among two or more groups is important in econometrics, statistics,
and other disciplines (Duan, 1983; O’Brien, 1988; Fenn et al., 1996; Lin et al., 1997; Hlatky
et al., 1997; Lin, 2000; Tu and Zhou, 1999).
To motivate our approach, let y11, . . . , y1n1 and y21, . . . , y2n2 be the observed non-zero costs
in the case and control groups. An obvious estimator of ∆ is the difference in sample means
y¯1− y¯2 where y¯g = 1ng
∑ng
i=1 ygi, g = 1, 2. Because we anticipate a highly skewed distribution
and one of the samples to be much smaller than the other (n1 < n2), this unbiased estimator
may be more variable than alternatives.
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One such alternative is the log-normal model, in which the logarithms of the expenditures are
assumed to follow normal distributions: log ygi ∼ N(νg, σ2g), i = 1, . . . , ng, g = 1, 2. Under
the log-normal assumption, the difference in mean expenditures for the two populations is by
∆ = exp(ν1 + σ
2
1/2)− exp(ν2 + σ22/2) (Aitchison and Shen, 1980). The maximum likelihood
estimate of ∆ is biased (Zellner, 1971), but has reduced variability relative to the sample
mean difference because it reduces the degree of dependence on the few largest observations.
Zhou et al. (1997) and Zhou and Gao (1997) have studied methods for testing the null
hypothesis that ∆ = 0 under the log-normal model. Many authors have used the log-normal
model for inferences about the mean of a non-zero random variable (Land, 1971; Angus,
1994; Duan et al., 1983; Zhou and Melfi, 1997; Lipscomb et al., 1999; Andersen et al., 2000).
An important limitation of the log-normal model for estimating total or mean costs results
from the symmetry inherent in the normal distribution for the logarithms of the expendi-
tures. When the mean expenditure is the scientific focus, the right tail of the distribution
contributes most to the mean; the smaller values in the left tail have less influence. Under
the symmetry assumption for the log expenditures, we assume that the right and left tails
have the same shape on the logarithm scale so that the very smallest expenditures in the
sample can be viewed as providing information about the largest ones. In most applications,
including the lung cancer and COPD expenditures problem that motivates this work, this
symmetry assumption is not based upon any meaningful mechanism and is not likely to be
realistic.
One way to view the limitation of the log-normal model to address skewness, is in terms of
the quantile-quantile or Q-Q plot. The quantile estimates of the two distributions are plotted
against each other (Wilk and Gnanadesikan, 1968; Doksum and Sievers, 1976; Parzen, 1979;
Nair, 1982; Wilcox, 1995). Under the log-normal model, the logarithms of the quantiles from
each distribution satisfy the linear equation:
logQ1(p) =
(
ν2 − σ2
σ1
ν1
)
+
σ2
σ1
logQ2(p) (1)
where Q1(p) and Q2(p) are the quantile functions of the random variables Y1 and Y2 rep-
resenting the non-zero expenditures for the case and control groups. If we use the mean
and variance of the log-transformed data to estimate the intercept and slope from the Q-Q
plot, then the smallest observations have as much influence on the intercept and slope as the
largest observations. This is clearly undesirable when the goal is to estimate the difference
in population means, especially when evidence exists in the Q-Q plot against the linearity
assumed. Figure 2 displays the Q-Q plot of the log expenditures for the cases versus those for
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the controls, as well as the straight line corresponding to the maximum likelihood estimates
of the log-normal parameters for each sample.
If evidence exists in the Q-Q plot against the linearity assumed under the log-normal model,
we might assume that Q1(p) is an arbitrary function of Q2(p), that is Q1(p) = g (Q2(p))
or equivalently F1(y) = F2 (h(y)) where Fg(y), g = 1, 2 are the cumulative distribution
functions of Y1 and Y2. Doksum and Sievers (1976) define h(.) as the amount of “shift”
needed to bring Y1s up to the Y2s in distribution. For example, we might assume that Q1(p)
is a smooth function of Q2(p) with λ degrees of freedom, Q1(p) = s(Q2(p), λ), where s is a
parametric or a non-parametric smoother.
There are three possible limitations of the shift model for application to the estimation of
∆. First, one might estimate Q1 and Q2 at a given set of percentiles and regress Q̂1 on Q̂2.
This regression approach leads to conditioning on Q2 rather than treating the two quantile
functions symmetrically, as would be natural when the target for inference is ∆. Second, the
smooth function s would take arguments on the positive real line making choice of λ critical.
Third, if we then use the fitted values from the smoother to calculate ∆ˆ, this estimate is
simply the difference in the sample means.
As an alternative, we assume that the log-quantile ratio is a smooth function of the percentile
p with λ degrees of freedom:
log
Q1(p)
Q2(p)
= s(p, λ), 0 < p < 1. (2)
This is the basic idea of Smooth Quantile Ratio Estimation (SQUARE). Differently from
the shift estimator (Doksum and Sievers, 1976), SQUARE “spends” its degrees of freedom λ
over the interval (0,1) rather than over the real line, and hence imposes stronger smoothness
constraints in the tails where little information is available in our smaller sample. As a result,
SQUARE produces an estimator of ∆ that tends to be less variable than the difference in
sample means. For different distributional assumptions, shapes of s(p, λ) and choices of
λ, SQUARE encompasses rich class of estimators including the sample mean difference,
the maximum likelihood estimate under log-normal samples, and L-estimates. SQUARE
borrows strength across neighboring percentiles of the distribution to reduce the variability
in the estimated mean difference rather than relying on symmetry assumptions inherent in
the log-normal model. In summary, the development of SQUARE is motivated by the needs
to: 1) address skewness without making fully parametric assumptions on the underlying
3
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distributions for the two samples; 2) treat the two samples symmetrically; 3) and expand
the class of estimators to include existing ones and others that may be very efficient in some
circumstances.
In section 2, we introduce SQUARE as a semi-parametric method using a parametric model
for the log-quantile ratio and non-parametric estimate of the quantile functions. In section 3,
we show that, under certain bounding conditions for the log-quantiles, SQUARE is consistent
and asymptotically normal. Here we also provide an explicit expression for the asymptotic
variance of SQUARE, and examples where our asymptotic results apply. In Section 4, we
present a simulation study that compares bias and variance properties of SQUARE with
the log-normal maximum likelihood estimate and the sample mean difference. Here we also
illustrate SQUARE with an analysis of the NMES data shown in Figure 1. In this section
we also illustrate a cross-validation method for estimating the number of degrees of freedom
λ. Section 5 is a discussion of opportunities for further development of this idea. Proofs of
the asymptotic results are detailed in the Appendix.
2 Smooth Quantile Ratio Estimation (SQUARE)
2.1 Definition
Let Y1 and Y2 be two positive random variables. For example in the motivating application,
these are the non-zero expenditures for the cases and controls, respectively. We consider the
two cumulative distribution functions F1 and F2, and define Q1 and Q2 to be the correspond-
ing quantile functions so thatQg(p) = F
−1
g (p) and Fg(Qg(p)) = Pr{Yg ≤ Qg(p)} = p, g = 1, 2
and 0 ≤ p ≤ 1. Our goal is to estimate the difference:
∆ = E[Y1]− E[Y2] =
∫ 1
0
{Q1(p)−Q2(p)}dp , (3)
assuming that the ratio of the quantiles is a smooth function of the percentiles with λ degrees
of freedom:
log
Q1(p)
Q2(p)
= s(p, λ), 0 < p < 1. (4)
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Then Equations (3) and (4), lead to:
∆ =
∫ 1
0
Q1(p) [1− exp (−s(p, λ))] dp =
∫ 1
0
Q2(p) [exp (s(p, λ))− 1] dp. (5)
2.2 Estimation Approach
Let y1 = (y11, y12, · · · , y1n1) be an iid sample of size n1 from F1, and y2 = (y21, y22, · · · , y2n2)
be an iid sample of size n2 from F2. We define y(g) = (yg(1), yg(2), · · · , yg(ng)) to be the order
statistics for the sample from Fg. We first estimate ∆ for the case n1 = n2 = n, and then
extend our definition to the more common situation n1 << n2.
The estimation approach can be described in two steps. First, we define a regression model
for s(p, λ) and we use it to smooth the observed log-ratio log(y(1)/y(2)) across percentiles
(parametric part). Second, we estimate ∆ by using the smoothed quantile ratios and non-
parametric estimates of F1 and F2 (non-parametric part). The two steps are detailed below.
Parametric step: we impose a smoothness assumption for s(p, λ) by assuming a regression
model:
log
y1(i)
y2(i)
= s(pi,β) + ²i, i = 1, . . . , n (6)
where: s(pi,β) =
∑λ
j=0Bj(pi)βj, pi = i/(n+ 1), and Bj(p) are orthonormal basis functions,
with B0(p) = 1. We estimate β̂ = (βˆ0, βˆ1, . . . , βˆλ) by ordinary least squares, although
alternative and more efficient methods could be substituted.
Non-parametric step: we define u1 = (y(1),y
?
(1)) and u2 = (y(2),y
?
(2)) to be two samples
of size 2n where y?1(i) = y2(i) exp
(
s(pi, β̂)
)
, and y?2(i) = y1(i) exp
(
−s(pi, β̂)
)
, and s(pi, β̂) be
the fitted values from the regression model (6). We estimate ∆ by:
ŜQ(λ) = u¯1 − u¯2
= 1
2n
∑n
i=1 y1(i)
[
1− exp
(
−s(pi, β̂)
)]
+ 1
2n
∑n
i=1 y2(i)
[
exp
(
s(pi, β̂)
)
− 1
]
.
(7)
ŜQ(λ) is then the sample mean difference of the two ”extended samples” ug, g = 1, 2, by
which we mean the vector of actual observations y(g) augmented with the transformed values
from the other sample y?(g). Therefore, it has the desirable property of being symmetric,
that is ŜQ(u1,u2, λ) = −ŜQ(u2,u1, λ) which is not necessarily shared by shift estimators.
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Furthermore, ŜQ(λ) can also be viewed as a linear combination of order statistics, but with
weights estimated from the data, and thus it is related to L-estimation (Huber, 1996; Serfling,
1980).
The motivating application for SQUARE is n1 < n2, that is, one sample is much smaller
than the other. Here we calculate ŜQ(λ) by replacing y2 by q2, the linear interpolation of
the order statistics y2(i) to the grid of points p1i = i/(n1 + 1), i = 1, . . . , n1. Similarly if
n1 > n2, then we replace y1 by q1, the linear interpolation of the order statistics y1(i) to the
grid of points p2i = i/(n2+1), i = 1, . . . , n2. This definition of SQUARE still maintains the
property of symmetry.
This paper focus on non-zero random variables, but a common difficulty in the statistical
analysis of expenditure data is the presence of a significant percentage of zero-cost observa-
tions. For example, in our application, the total number of cases and controls are N1 = 188
and N2 = 9228, respectively. Among these only n1 = 118 and n2 = 2262 have non-zero
expenditures, the remaining N1 − n1 = 70 and N2 − n2 = 6966 have observations with
zero costs. If we let pi1 = P (Y1 > 0) and pi2 = P (Y2 > 0) be the probabilities of non-zero
expenditure the disease and control groups, respectively, and let µ1 = E[Y1 | Y1 > 0] and
µ2 = E[Y2 | Y2 > 0] be the mean of the non-zero values in the disease and control groups,
then we seek to estimate ∆ = pi1µ1 − pi2µ2. It is appropriate to revise Equation (7) as
ŜQ(λ) = pˆi1u¯1 − pˆi2u¯2 where pˆij is the fraction of non-zero responses for population j.
2.3 Special Cases of SQUARE
In the previous section we have illustrated how to estimate ∆ with SQUARE, that is by
using a semi-parametric procedure where: 1) we first estimate s(p,β) by taking the fitted
values from the regression model (6); 2) given the estimated s(p, β̂), we estimate ∆ non
parametrically. For different shapes of s(p,β), choices of the basis functions Bj(p), and
specifications of parametric cdf, SQUARE encompasses a very large class of estimators.
Below are detailed some special cases.
1. ŜQ(Unif, λ = 0): s(p,β) is constant and Yg, g = 1, 2 are uniform r.v. We assume
Yg ∼ U [0, θg], then Q1(p)/Q2(p) = θ1/θ2 and ∆ = (θ1− θ2)/2. The SQUARE estimate
of ∆, denoted as ŜQ(Unif, λ = 0) is obtained by: 1) fitting the regression model (6)
with B0(p) = 1 and B1(p) = 0, and 2) using s(pi, β̂) = βˆ0 = l¯y1− l¯y2 where ly = log(y)
6
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in equation (7). This leads to ŜQ(Unif, λ = 0) = 1
2
[
y¯1(1− exp(−β̂0))− y¯2(1− exp(β̂0))
]
.
Note that ŜQ(Unif, λ = 0) is not the MLE of ∆ which is equal to (y1(n) − y2(n))/2.
2. ŜQ(LN, λ = 1): s(p,β) is linear in Φ−1(p) and Yg, g = 1, 2 are log-normal
r.v. We assume Yg ∼ LN(νg, σg), then log(Q1(p)/Q2(p)) = β0 + β1Φ−1(p) where
Φ−1(p) is the quantile function of the Normal r.v., β0 = (ν1 − ν2), β1 = (σ1 − σ2),
and ∆ = exp(ν1 + σ
2
1/2) − exp(ν2 + σ22/2). The SQUARE estimate of ∆, denoted as
ŜQ(LN, λ = 1), is obtained by: 1) fitting the regression model (6) with B0(p) = 1
and B1(p) = Φ
−1(p), and 2) using s(pi, β̂) = βˆ0 + βˆ1Φ−1(pi) in equation (7). Note
that ŜQ(LN, 1) is not the MLE of ∆, which instead is defined as LN = exp(l¯y1 + s
2
1/
2) − exp(l¯y2 + s22/2), where ly = log y and s is the standard deviation of the log-
transformed data. Also note that, if σ1 = σ2, then s(p, λ) is constant in p and equal
to β0.
3. The sample mean difference: s(p,β) interpolates the log-quantile ratios.
Here n1 = n2 = n = λ and the basis functions in (6) can be chosen so that s(p, β̂)
interpolates the values log
(
y1(i)
y2(i)
)
. In this case, we treat the two samples as independent
and we do not borrow strength from one distribution to the other in estimating ∆. Here
SQUARE reduces to the difference in sample means y¯1 − y¯2.
4. L-estimates: s(p,β) is known but with unspecified shape. Equation (7) shows
that, if s(p,β) is known then SQUARE is the average of two L-estimates (Huber,
1981).
3 Asymptotic Properties of SQUARE
In this section we show that the random coefficients β̂ and SQUARE itself are both asymp-
totically normal. We give explicit expressions for the variance of each.
Theorem 1 Consistency and asymptotic normality of β̂ Assume n1, n2 → ∞ and
there exist M, b1, b2 and δ > 0 such that
A) | logF−1g (p)| ≤Mp−1/2+b1+δ(1− p)−1/2+b2+δ, for g = 1, 2,
7
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B) the basis functions |Bj(p)| are continuously differentiable on (0, 1) and |Bj(p)| ≤Mp−b1(1−
p)−b2
then β̂j is strongly consistent for βj, j = 0, 1, . . . , λ. In addition, if we assume that
C) the limit limn1,n2→∞ n1/(n1 + n2) exists and is in the interval (0, 1)
then β̂ − β has an asymptotic multivariate normal distribution with mean 0 and covariance
matrix Σ = (σij) where
σij =
{
1
n1
+
1
n2
}∫ 1
0
∫ 1
0
(min{p, q} − pq)Bi(p)Bj(q)dpdq.
Remark 1 For consistency alone, the first condition can be replaced by the following relaxed
condition
A
′
)
∫ | log Yg|rdFg(x) <∞, | logF−1g (p)| ≤Mt−1+b1+δ(1− t)−1+b2+δ, for g = 1, 2.
Proof: The consistency and asymptotic normality of individual coefficients β̂j is an im-
mediate corollary to the L-statistic results of Shorack Shorack (1972) and Wellner Wellner
(1977). The Cramer-Wold device is applied to show that β̂ − β has an asymptotic multi-
variate normal distribution. See, for example, Billingsly ? for details of Cramer and Wold’s
method.
Asymptotic Normality of SQUARE The principal result of this section is the following
proof that ∆̂−∆ has an asymptotic normal distribution. Our general approach will be the
the differentiable statistical functional method (functional δ-method) developed by von Mises
and described in (Serfling, 1980). To use this method, we establish an asymptotic equivalence
between the SQUARE estimator and the functional below, to which we can adapt the von
Mises framework. Details of this result, including a proof of the equivalence, are found at
Cope (2003). Our functional takes the form:
T (F1, F2) =
1
2
∫ 1
0
F−11 (p) (1− exp{−s(p,β)}) dp+
1
2
∫ 1
0
F−12 (p) (exp{s(p,β)− 1}) dp
8
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where
s(p,β) =
λ∑
j=0
βvjBj(p),
and
βj =
∫ 1
0
Bj(p)
[
log
(
F−11 (p)
)− log (F−12 (p))] dp.
so that the functional version of the estimator is given by T (F̂1, F̂2). To prove asymptotic
normality, we expand the functional in a one term Taylor series. The directional derivative
of the functional at the point (F1, F2) converges to a Gaussian distribution. If the remainder
converges in probability to zero, then the estimator, like the derivative, has a Gaussian
limiting distribution.
The assumptions are bounding conditions very similar to those required to prove that L-
estimators are asymptotically normal.
Theorem 2 Assume that n1, n2 → ∞ and that λg = limn1,n2→∞ n1/(n1 + n2) exists and
lies in (0, 1). Suppose there exist M, b, and δ > 0 such that the following conditions hold for
g = 1, 2, j = 1, 2, . . . , k and all p ∈ (0, 1)
A) F−1g ≤M(p(1− p))−b+δ and | logF−1g | ≤M(p(1− p))−1/2+δ,
B) exp
{
(−1)g∑λj=1 βjBj(p)} ≤M(p(1− p))−1/2+b,
C) |Bj(p)| ≤M(p(1− p))−δ/(δ+2).
Then
√
n
(
∆̂−∆
)
has an asymptotic normal distribution with mean 0 and variance σ2
where
σ2 =
∫ 1
p=0
∫ 1
q=0
(min(p, q)− pq) (λ1η1(p)η1(q) + λ2η2(p)η2(q)) dpdq, (8)
and
ηg(p) =
F−1g (p) +
1
2
(
F−11 (p) + F
−1
2 (p)−
∫ 1
q=0
∑K
j=1Bj(q)
(
F−11 (q) + F
−1
2 (q)
)
dq
)
(−1)gF−1g (p)fg
(
F−1g (p)
) .
9
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A sketch of the proof is found in the appendix. Weak consistency is obtained as a corollary
to asymptotic normality.
We conclude with a couple of examples to which our asymptotic results apply.
Example 1 If both samples are drawn from lognormal distributions, then SQUARE is con-
sistent and asymptotically normal. In this case, Fg = Φ(
log x−µg
σg
), F−1g = exp {µg + σgΦ−1(p)} ,
and logF−1g = µg + σgΦ
−1(p), where Φ is the standard normal distribution function. The
log-quantile ratio is a linear function of Φ−1(p) so a natural orthonormal basis is B0 ≡ 1 and
B1 = Φ
−1(p).
Example 2 If both samples are drawn from Pareto distributions with cdf F (x) = 1− bax−a
and a > 2, then SQUARE is strongly consistent and asymptotically normal. The Pareto
distribution makes an interesting example for SQUARE because it is very heavy tailed, and
has a finite kth moment only if the shape parameter a ≥ k. Its density function is f(x) =
abax−a−1, where x ≥ 1 and a, b > 0. The log-quantile function is given by logF−1(p) =
log b − log(1 − p)/a leading to the two basis functions B0(p) ≡ 1 and B1(p) = log(1 − p).
Note that the orthonormalized version of B1 is equal to (log(1− p) + 1)/
√
(3).
4 Simulations and Data Analysis
This section demonstrates that ŜQ(λ) (for moderate λ, and for λ estimated from the data)
has substantially lower mean squared error and bias than common used estimators of ∆,
such as the maximum likelihood estimator for log-normal populations and the sample mean
difference.
More specifically, we estimate λ by use of a B-fold cross-validation method (Efron, 1983;
Breiman and Spector, 1992; Efron and Tibshirani, 1993; Shao and Tu, 1995) which minimizes
CV (λ) =
B∑
b=1
[
(y¯
(b)
1 − y¯(b)2 )− ŜQ
(−b)
λ
]2
(9)
where (y¯
(b)
1 − y¯(b)2 ) is the sample mean difference applied to the two b-th random sub-vectors
10
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for the cases and the control (the training sets) a ŜQ
(−b)
λ is the SQUARE estimate obtained
with the rest of the data. We choose B = 10 and we minimizes CV (λ) for λ = 1, 2, 4, 6, 8.
Data are generated under 4 scenarios, A, B, C, and D. Under each scenario, we compare bias
and variance properties of the following six estimators of ∆: 1) ŜQ(λ̂) where λ̂ is estimated
by minimizing CV (λ) in equation (9); 2)ŜQ(λ = 2); 3) ŜQ(λ = 4); 4) SQUARE under the
assumption that the two populations are log-normal ŜQ(LN, 1); 5) the maximum likelihood
estimator under the log-normal model LN ; and 6) the sample mean difference y¯1 − y¯2.
Table 1 and Figure 3 summarize the four scenarios studied. The first three scenarios A,B and
C, are theoretical distributions in which population 2 is log-normal with mean ν2 = 7 and
standard error σ2 = 1.5. These parameters were chosen to roughly approximate the sample
statistics from the medical expenditures datasets for non-diseased subjects. In scenario
A, population 1 is is also log-normal with a higher mean ν1 = 7.5 and a higher standard
error σ1 = 1.75. In scenarios B and C, population 1 differs from 2 by the functions s(p)
shown in figure 3, chosen to represent a range of plausible shapes. We also studied ŜQ(λ)’s
performance for the empirical expenditure distribution drawn from the NMES data. Scenario
D, whose log-quantile functions are pictured in Figure 3 with dark solid lines, contrasts the
distributions of non-zero medicare expenditures for 118 lung cancer or COPD patients to
2262 controls.
In our simulations, we generated 500 data sets for each scenario, and we compared estimators
with equal sample sizes n1 = n2 = 100 and unequal samples with n1 = 100, n2 = 1000.
The results were qualitatively similar and hence we report only the unequal case. For each
generated data set, we estimate SQUARE for λ̂ and for λ = 2, 4 by use of natural cubic
splines as basis functions.
These results show that ŜQ outperforms both y¯1− y¯2 and the log-normal estimators in terms
of MSE. Table 2 presents the relative mean square error (MSE) as a percent of the MSE for
y¯1 − y¯2, e.g.
(
mse(y¯1 − y¯2)−mse(∆̂)
)
/mse(y¯1 − y¯2). Negative values imply that y¯1 − y¯2 is
preferred, positive percents favor the comparator ∆̂.
In scenario A, when both populations are log-normal, ŜQ(λ̂) and ŜQ(λ) for λ = 2, 4 are
52, 49 and 40 percent better than y¯1− y¯2. Note that the SQUARE estimates perform better
even than the log-normal MLE (LN) which in this case is asymptotically efficient. This is
because the relatively small sample size of the case group (n1 = 100) leads to a maximum
11
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likelihood estimate of E[Y1] that is less efficient than the sample mean of the extended
sample u¯1. By borrowing strength from the distribution in the control group, SQUARE
gains efficiency in estimating E[Y1].
In scenario B, the six estimators have comparable performance and they are all superior
than the sample mean difference. In scenarios C and D, the estimates ŜQ(LN, 1) and LN
performs very poorly due to the substantial non-linearity of s(p) whereas the SQUARE
estimates are 51, 54 and 44 percent better than the sample mean difference. Finally, for the
empirical scenario D, the SQUARE estimates are 20 percent better than the sample mean
difference, and again the log-normal estimators performs very poorly.
Table 3 summarizes bias of ∆̂ as a percent of the true ∆, e.g.
(
E(∆̂)−∆
)
/∆, and shows
that ŜQ(λ) has small percent bias in the cases considered. In most cases the bias of the
SQUARE estimates is comparable to the bias of the sample mean difference, which is unbi-
ased in large samples. As expected, the bias of ŜQ(LN, 1) is small only when s(p) is almost
constant. Finally, except in scenario A when the two populations are log-normal, the LN is
badly biased.
We have also performed a sensitivity analysis of SQUARE to the choice of the basis functions.
For each of the 500 data sets, and for each scenario, we estimate s(p) by using, in addition to
the natural cubic splines, smoothing splines and polynomials. These estimates are all close
to each other and to the true s(p) (results not shown) .
Finally, we analyze the NMES data represented in Figures 1 and 2, also used as scenario D,
to estimate the mean difference between annual Medicare expenditures for persons with lung
cancer or COPD (cases), diseases caused largely by smoking, and otherwise similar persons
without these two smoking-attributable diseases (controls). In addition to estimating the
overall mean difference in expenditures for persons with and without disease caused by
smoking, a second question is whether this difference is smaller for smokers who perhaps
seek or receive fewer services. That is, does smoking status modify the difference in medical
expenditures between the cases and the controls? Table 4 shows the number of disease cases
and controls for smokers (current or former), and for the non-smokers (never). The numbers
within parentheses represent the percentage of people in that cell with non-zero expenditures.
The percentage of cases with non-zero expenditures is more than twice as large as for the
controls (65% and 25%); this is consistent with our expectation that people with disease
receive more services. These proportions are similar for smokers and non-smokers.
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We apply the two-part analogues of the: 1) SQUARE estimates, 2) maximum likelihood
estimator under log-normal population; and 3) weighted difference in the sample means
to the NMES data base, and to the subset of the NMES data for smokers only. Figure
4 summarizes boxplots of 100 bootstrap estimates of ∆ for everyone and for the smokers
only. Simulation study results suggest that the SQUARE estimates are far more efficient
with respect to the selected competitors. In addition the non-linearity of the estimated
s(pi,β) (bottom right panel of Figure 3) also suggests that and that the maximum likelihood
estimator (LN) is likely to be highly biased. As expected the estimator ŜQ(λ̂) is more variable
than the SQUARE estimates with λ known, because it also takes into account of the model
uncertainty. Estimates for the smokers are slightly larger than for everyone.
5 Discussion
In this paper, we have proposed a novel class of estimators of the difference of the expected
values of two skewed distributions that encompasses most of the current approaches. Our
innovative approach model the log-ratio of the two quantile functions as a smooth function
of the percentiles where the degree of smoothness can be estimated from the data. By
smoothing across percentiles, we borrow strength across the two samples and produce an
estimator that is more efficient than the difference in sample means and log-normal estimators
in the cases relevant to the motivating approach. In summary, SQUARE is a semi-parametric
method using a parametric model for smoothing the log-quantile ratios across percentiles,
and a non-parametric estimator of the two quantile functions. The software for implementing
SQUARE and the data for reproducing all the analyses reported in this paper are available
at http://biostat.jhsph.edu/∼fdominic/square.html.
The idea of linking two samples in a semi-parametric model is obviously not new. Perhaps
the most famous and influential example is the Cox proportional hazards model (Cox, 1972)
where the target is the hazard ratio. A second example is the density ratio model of Qin and
Zhang (1997). Here, the ratio of densities f(x)/g(x)is assumed to be a smooth function of x.
This model would lead to an estimator of the mean difference that is analogous to ours but
where a smooth function of the unordered data is used in Equation 7 rather than a smooth
function of the order statistics. There is a fundamental difference in the two approaches. We
smoothly map the random variables themselves to one another; they map their probabilities.
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SQUARE encompasses and generalizes a large class of estimators including L-estimates (Hu-
ber, 1996; Serfling, 1980). If s(p) is known, then SQUARE is a linear combination of order
statistics. If s(p) is unknown, then SQUARE is still a linear combination of order statistics,
but with weights estimated from data. This fact has been exploited to develop the asymp-
totic theory presented in this paper, which owes much to the L-estimation results of Shorack
(1972), Wellner (1977), Boos (1979), and Serfling (1980).
Under certain bounding conditions for the quantile functions, we showed that SQUARE is
consistent and asymptotically normal. We provided an explicit expression for the asymp-
totic variance of SQUARE, and examples where our asymptotic results apply. Although the
bounding conditions included in the theorems may appear awkward, their purpose is quite
straightforward: these bounds are sufficient to ensure that all integrals are bounded in prob-
ability. The bounds are tight and cannot be relaxed, but other combinations of conditions
will suffice as well.
For an arbitrary pair of distributions, it is not guaranteed that the quantile ratio falls within
the span of any pre-defined and finite basis. Therefore it is important to allow the basis to
grow with the sample. Asymptotic normality can generally be extended to this case if the size
of the basis is no greater than log n. We do require some regularity conditions on the basis
for this result to hold, but for square-integrable, log quantile functions, we can guarantee
the existence of a suitable basis. An extensive discussion of the asymptotic properties of
SQUARE and its relationships with L-estimation is reported in Cope (2003).
In the simulation study, we showed that SQUARE out-performs the sample mean difference
and the log-normal MLE estimator for moderate values of the smoothing parameter λ and for
λ estimated by use of cross-validation methods. We also performed a simulation study where
we sample Y1 and Y2 from exponential distributions. Here the maximum likelihood estimator
of the mean difference of two exponential random variables is the sample mean difference,
and SQUARE’s performance is similar to the MLE. As an alternative to SQUARE, we could
assume that Qlog Y1(p) = s(Qlog Y2(p), λ), and estimate ∆ by using the fitted values of the
QQ-plot. In our simulation study we compared this estimator with SQUARE. We found
that, although this is certainly a reasonable estimation approach, it is not as efficient as
SQUARE.
The development of SQUARE was motivated by the estimation of smoking attributable
medical expenditures. A key component is to estimate the mean medical expenditures be-
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tween persons with smoking attributable-diseases (e.g. lung cancer or COPD) and otherwise
similar persons without such diseases. Our analysis of expenditures allows smoking status
to modify the effect of disease on expenditures. We examine this effect modification first
by stratifying the cases and the controls with respect to their smoking status, and then by
estimating SQUARE separately for smokers and non-smokers, within each stratum.
However, a more desirable goal would be to compare medical expenditures for cases and
controls taking into account individual-level characteristics x. In this case SQUARE can be
extended to the regression case by assuming
logQ1(p;x) = logQ2(p;x) + s(p;x). (10)
To control for systematic differences in covariates between two populations, a common strat-
egy is to group units into subclasses based on covariate values, for example using propensity
score matching (Cochran and Rubin, 1973; Rubin, 1973), and then estimate SQUARE within
strata of propensity scores. The extension of SQUARE to the regression case, and a com-
parison between regression SQUARE and common econometric models such as a two-part
log-linear regression models (Duan, 1983; Mullahy, 1998; Mullahy and Manning, 1995) is
exploited in Dominici and Zeger (2003).
The potential applications of SQUARE are numerous. For example, in clinical trials our
approach can be used to estimate treatment effects that vary smoothly with respect to the
percentiles of the health outcome. If Y has a more nearly symmetric distribution, rather
than smoothing the ratio of the quantiles, we can smooth their difference; that is, we can
assume Q1(p) − Q2(p) = s(p). Under this model, we estimate the treatment effect, ∆, by∫
s(p)dp. The plot of the estimated s(p) versus p is also informative for identifying the
outcome percentiles where the treatment is mostly effective.
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6 Appendix
In using the differentiable statistical functional approach, the largest task is to demonstrate that the remain-
der
R1 =
√
n
(
T (F̂ )− T (F )− d1
(
T, F ;
√
n(F̂ − F )
))
converges to zero in distribution. If the remainder vanishes in the limit, then
√
n
(
T (F̂ )− T (F )
)
is equivalent
to d1
(
T, F ;
√
n(F̂ − F )
)
and the asymptotic properties of the former can be derived from the latter. In the
case of SQUARE, the derivative (??) is given by
d1
(
T, F ;
√
n(F̂ − F )
)
=
√
nλ1
∫ 1
p=0
(
F1(F̂−11 (p))− p
)
η1(p)dp
+
√
nλ2
∫ 1
p=0
(
F2(F̂−12 (p))− p
)
η2(p)dp. (11)
Both
√
nλ1
(
F1(F̂−11 (p))− p
)
and
√
nλ2
(
F2(F̂−12 (p))− p
)
converge to Brownian bridges, so the derivative
has a normal asymptotic distribution with variance σ2 as defined above.
Sketch of proof that the remainder converges to zero. At points in this proof it is
necessary to evaluate expressions like
∫ 1
p=0
F̂−1(p)Jn(p)dp where F̂−1 is an empirical quantile function and
Jn(p) may also be data dependent. In order to simplify treatment of these expressions, the following lemma
establishes conditions under which the range of integration can be truncated.
Lemma 1 Let x1, x2, . . . , xn be an i.i.d. sample. Suppose that F̂−1 is the empirical quantile function
corresponding to this data, and let Jn : (0, 1) → < be a possibly random function. Assume that there exist
positive constants M, b and δ such that
A) the quantile function F−1(p) ≤M(p(1− p))−b+δ, and
B) the random function |Jn(x)| ≤
(
M(p(1− p))−1/2+b)1+²n where ²n p→ 0.
Then
Tn =
√
n
(∫ k/n
0
F̂−1(p)Jn(p)dp+
∫ 1
(n−k)/n
F̂−1Jn(p)dp
)
p→ 0.
The proof is not included here.
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We break the remainder up into several pieces and prove convergence separately for each piece. Here R1,n
can be written as
1
2
∫ 1
p=0
√
n
(
F̂−11 (p)
2 −
F−11 (p)
2 −
[F̂1(F−11 (p))−p]
2f1(F
−1
1 (p))
)
(1− exp (−s(p,β))) dp,
− 12
∫ 1
q=0
√
n
2 F
−1
1 (q)
[
exp
(
−s(q, β̂)
)
− exp (−s(q,β))
− exp (−s(q,β))∑j Bj(q) ∫ 1p=0Bj(p) [ [F̂1(F−11 (p))−p]F−11 (p)f1(F−11 (p)) − [F̂2(F−12 (p))−p]F−12 (p)f2(F−12 (p))
]]
dpdq,
+ 12
∫ 1
p=0
[
exp
(
−s(p, β̂)
)
− exp (−s(p,β))
] [
F̂−11 (p)− F−11 (p)
]
dp

(12)
+ 12
∫ 1
p=0
√
n
(
F̂−12 (p)
2 −
F−12 (p)
2 −
[F̂2(F−12 (p))−p]
2f2(F
−1
2 (p))
)
(exp(s(p,β))− 1) dp,
+ 12
∫ 1
q=0
√
n
2 F
−1
1 (q)
[
exp
(
s(q, β̂
)
− exp(s(q,β))
− exp(s(q,β))∑j Bj(q) ∫ 1p=0Bj(p) [ [F̂1(F−11 (p))−p]F−11 (p)f1(F−11 (p)) − [F̂2(F−12 (p))−p]F−12 (p)f2(F−12 (p))
]]
dpdq,
+ 12
∫ 1
p=0
[
exp
(
s(p, β̂
)
− exp(s(p,β))
] [
F̂−12 (p)− F−12 (p)
]
dp.

(13)
Only (12) is examined here since the treatment of (13) is identical.
Our first step is to rewrite (12) as R1 +R2 +R3 where we define
R1 =
√
n
2
∫ 1
p=0
F̂−11 (p)− F−11 (p)−
[
F̂1(F−11 (p))− p
]
f1(F−11 (p))
 (1− exp (−s(p,β))) dp,
R2 = −
∫ 1
q=0
√
nF−11 (q)
 exp(−s(q,β̂))−exp(−s(q,β))
2 − exp (−s(q,β))
×∑λi=0Bi(q) ∫ 1p=0Bi(p) [ [F̂1(F−11 (p))−p]2F−11 (p)f1(F−11 (p)) − [F̂2(F−12 (p))−p]2F−12 (p)f2(F−12 (p))
]]
dpdq,
and
R3 =
√
n
2
∫ 1
p=0
[
exp
(
s(p, β̂
)
− exp(s(p,β))
] [
F̂−12 (p)− F−12 (p)
]
dp.
R1 is the remainder from the differentiable statistical functional representation of an L-statistic and converges
in probability to zero.
After a little bit of algebra, R2 can likewise largely be expressed in terms of L-statistic remainders and
demonstrated to converge in probability to zero. With some manipulation, R2 can be written as
R2 =
√
n
2
∫ 1
p=0
log F̂−11 − logF−11 −
[
F̂1(F−11 (p))− p
]
F−11 (p)f1(F
−1
1 (p))

×
λ∑
j=1
Bj(p)
∫ 1
q=0
F−12 Bj(q)dq, (14)
17
Hosted by The Berkeley Electronic Press
+
√
n
2
∫ 1
p=0
log F̂−12 − logF−12 −
[
F̂2(F−12 (p))− p
]
F−12 (p)f2(F
−1
2 (p))

×
λ∑
j=1
Bj(p)
∫ 1
q=0
F−12 Bj(q)dq, (15)
+
√
n
2
∫ 1
p=0
F−12 (p) exp
−∑
j
ξjBj(p)
∑
j
(
(β̂j − βj)Bj(p)
)2
dp. (16)
Each of the first two terms, (14) and (15), is the remainder from the differentiable statistical functional form
of an L-statistic with functional, and so converges in probability to zero.
It remains to deal with (16), as well as R3. We have
exp
−∑
j
ξjBj(p)
 ≤ exp
∣∣∣∣∣∣
∑
j
βjBj(p)
∣∣∣∣∣∣
1+Γn ,
and thus
√
n
2
∫ 1
p=0
F−12 (p) exp
−∑
j
ξjBj(p)
∑
j
(β̂j − βj)Bj(p)
2 dp
≤ n1/2M1+Γn2 max
i
(
β̂i − βi
)2∫ 1
p=0
(
(p(1− p))−1/2+δ2/(δ+2)
)1+Γn
dp. (17)
Setting F̂−1(p) ≡ 1, Lemma 1 can be applied so that (17) is bounded from above by
M3max
i
(
β̂i − βi
)2
n1/2+(1/2−δ
2/(δ+2))(1+Γn).
When n is sufficiently large (and so Γn is sufficiently small), then the exponent on n is less than 1, ensuring
convergence in probability.
The final term, R3 is handled in very similar fashion. We first apply the mean value theorem to represent
exp
(
s(p, β̂
)
− exp(s(p,β)) in the form exp
(
−∑λj=1 ξjBj(p))∑j Bj(p)(β̂j − βj), where the ξj are strictly
between β̂j and βj . Then, defining F−12 .= F̂−12 (p)− F−12 (p), we have
R3 =
√
n
2
∫ 1
p=0
exp
− λ∑
j=1
ξjBj(p)
∑
j
Bj(p)(β̂j − βj)F−12 dp
≤
√
n
2
∑
j
|β̂j − βj |
∫ 1
p=0
exp
∣∣∣∣∣∣
λ∑
j=1
βjBj(p)
∣∣∣∣∣∣
1+Γnmax
j
|Bj(p)|F−12 dp
≤
√
n
2
∑
j
|β̂j−βj |
∫ 1
p=0
exp
∣∣∣∣∣∣
λ∑
j=1
βjBj(p)
∣∣∣∣∣∣
(max
j
|Bj(p)|+1
)1+ΓnF−12 dp.
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(18)
Truncating the integrals and applying the bounding functions, we can see that (18) is asymptotically equiv-
alent to
√
n
2
∑
j
|β̂j − βj |
∫ n/(n+1)
1/(n+1)
exp
∣∣∣∣∣∣
λ∑
j=1
βjBj(p)
∣∣∣∣∣∣
(max
j
|Bj(p)|+ 1
)1+ΓnF−12 dp
≤ M1+Γn2 n(1−b)(1+Γn)
∑
j
|β̂j − βj ||X2 − µ2|.
The random exponent Γn converges to zero at the same
√
n-rate as does
∑
j |β̂j − βj ||. Also |X2 − µ2|
converges to zero at a
√
n-rate, and so R3 converges in probability to zero.
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Table 1: Description of the sampling mechanisms used under each simulation study scenario. Fˆg, g = 1, 2
are the empirical cdfs of the non-zero Medicare expenditures for patients in the case and control groups.
g(y) = exp(log 7 + Φ−1(y) log 1.5) and Φ is the cdf of a standard Gaussian variable.
Scenario Population 1 Population 2 n1 n2
A y1 ∼ LN(7.5, 1.75) y2 ∼ LN(7, 1.5) 100 1000
B u ∼ Unif[0, 1], y1 = g(u)esB(u) y2 ∼ LN(7, 1.5) 100 1000
C u ∼ Unif[0, 1], y1 = g(u)esC(u) y2 ∼ LN(7, 1.5) 100 1000
D y1 ∼ Fˆ1 y2 ∼ Fˆ2 118 2262
Table 2: Mean squared error relative to y¯1 − y¯2 defined by
(
(mse(y¯1 − y¯2)−mse(∆ˆ))/mse(y¯1 − y¯2)
)
× 100
under the data generation mechanisms described in Section 3. The degrees of freedom λ are estimated by the
cross-validation approach illustrated in equation (9) for B = 10.
Percent Efficiency
∆ˆ Scenario A Scenario B Scenario C Scenario D
ŜQ(λ̂) 52 36 51 20
ŜQ(2) 49 38 54 21
ŜQ(4) 40 30 44 20
ŜQ(LN, 1) 50 40 -316 -196
LN 37 41 -3353 -1311
Table 3: Percent bias relative to y¯1 − y¯2 defined by
(
(E(∆ˆ)−∆)/∆
)
× 100 under the data generation
mechanisms described in Section 3. The degrees of freedom λ are estimated by the cross-validation approach
illustrated in equation (9) for B = 10.
Percent bias
∆ˆ Scenario A Scenario B Scenario C Scenario D
ŜQ(λ̂) -11 -21 3 3
ŜQ(2) -8 -18 4 7
ŜQ(4) -2 -7 3 3
ŜQ(LN, 1) -3 -24 39 45
LN 8 -27 119 111
y¯1 − y¯2 0 -3 -2 1
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Table 4: Disease cases and controls for smokers (current or former) and for non-smokers. Numbers within
parentheses represent the percentage of people in that cell with non-zero expenditures.
Smokers Non Smokers Everyone
cases 165 (64%) 23 (70%) 188 (65%)
controls 4682 (32%) 4546 (28%) 9228 (25%)
4847 (32%) 4569 (18%) 9416 (25%)
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Figure 1: Histograms of non-zero Medicare medical expenditures for the 1987 National Medical Expenditure
Survey (NMES) with and without a logarithm transformation, and for individuals in the case and control
groups. For clarity of exposition the histogram of the expenditures has been truncated at the top. On top
of the histograms of the log expenditures are density functions from Normal distributions with means νˆ1 =
1
n1
∑n1
i=1 log y1i, νˆ2 =
1
n2
∑n2
i=1 log y2i, and variances σˆ
2
1 =
1
n1
∑n1
i=1(log y1i−νˆ1)2, σˆ22 = 1n2
∑n2
i=1(log y2i−νˆ2)2,
for the case and control groups, respectively.
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Figure 2: Quantile-Quantile (Q-Q) plot of log non-zero Medicare expenditures for cases and controls.
Solid line is the Q-Q plot assuming each sample is from a log-normal model with parameter values estimated
by maximum likelihood.
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Figure 3: Theoretical (A-C) and empirical (D) s(p) curves. In scenario D, the solid curve is log
(
y1(i)
q2(i)
)
plotted at the percentiles p1i = i/(n1 + 1), i = 1, . . . , n1, where q2(1), . . . , q2(n1) are the order statistics of the
y21, . . . , y2n2 interpolated at percentiles p1i. The vertical segments represent the 95% point-wise confidence
intervals obtained for a bootstrap.
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Figure 4: Boxplots of 100 bootstrap samples of the estimated mean differences of Medicare expenditures
for people with and without smoking-attributable diseases. Results are reported for everyone in the sample
(N1 = 188, N2 = 9228) and for smokers only (N1 = 165, N2 = 4862).
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